Art

J-GLOBAL ID：202002261011200824   Reference number：20A2015289

Corneal Perforation during Combination Chemotherapy including Cetuximab in a Patient with a History of Herpetic Keratitis

ヘルペス性角膜炎歴のある患者におけるセツキシマブを含む併用化学療法中の角膜穿孔【JST・京大機械翻訳】

Author (6)： Aomatsu Keiichi (Department of Ophthalmology, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan) ,  Sugioka Koji (Department of Ophthalmology, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan) ,  Kodama-Takahashi Aya (Department of Ophthalmology, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan) ,  Fukuda Masahiko (Department of Ophthalmology, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan) ,  Mishima Hiroshi (Department of Ophthalmology, Nara Hospital, Kindai University Faculty of Medicine, Nara, Japan) ,  Kusaka Shunji (Department of Ophthalmology, Kindai University Faculty of Medicine, Osaka, Japan)
Material： Case Reports in Oncological Medicine (Web)
Volume： 2020  Page： Null  Publication year： 2020 
JST Material Number： U7850A  ISSN： 2090-6706  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Purpose. To report a case of c...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2015289&from=J-GLOBAL&jstjournalNo=U7850A") }}

Thesaurus term： Heredity ,  *Cornea ,  iris (eye) ,  Radiotherapy ,  man ,  parenchymatous keratitis ,  *Keratitis ,  monoclonal antibody ,  *herpetic keratitis ,  EGF receptor ,  Conservative Treatment ,  donor ,  *Corneal Perforation ,  *Polypharmacy
Semi thesaurus term： *多剤併用療法 ,  *セツキシマブ , 【Automatic Indexing@JST】

JST classification (2)： Eye diseases  (GP03000U) ,  Infectious diseases,parasitics diseases in general.  (GD01010H)

Reference (11)：

• C. G. Foerster, C. Cursiefen, F. E. Kruse, "Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)," Cornea, vol. 27, no. 5, pp. 612-614, 2008.
• H. Kawakami, K. Sugioka, K. Yonesaka, T. Satoh, Y. Shimomura, K. Nakagawa, "Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis," Journal of Clinical Oncology, vol. 29, no. 23, pp. e678-e679, 2011.
• A. M. McElvanney, "Doxycycline in the management of pseudomonas corneal melting," Eye & Contact Lens: Science & Clinical Practice, vol. 29, no. 4, pp. 258-261, 2003.
• S. E. Wilson, Q. Liang, W. J. Kim, "Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding," Investigative Ophthalmology & Visual Science, vol. 40, no. 10, pp. 2185-2190, 1999.
• J. D. Zieske, H. Takahashi, A. E. Hutcheon, A. C. Dalbone, "Activation of epidermal growth factor receptor during corneal epithelial migration," Investigative Ophthalmology & Visual Science, vol. 41, no. 6, pp. 1346-1355, 2000.

Terms in the title (5)： ヘルペス性角膜炎 ,  患者 ,  セツキシマブ ,  併用化学療法 ,  角膜穿孔